Michael S. Seaman

41.9k citations

224 papers · 14.2k · 4 hit papers · h-index 66

Impact in

Virology top 0.01%
- HIV Research and Treatment
Immunology top 0.1%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses

Papers in

Virology 190
- HIV Research and Treatment 182
Immunology 119
- Immune Cell Function and Interaction 92
- T-cell and B-cell Immunology 41
- Immunotherapy and Immune Responses 19

Co-authors: Michel C. Nussenzweig (42 shared papers)Florian Klein (19 shared papers)David C. Montefiori (30 shared papers)John R. Mascola (26 shared papers)Johannes F. Scheid (14 shared papers)Hugo Mouquet (13 shared papers)Pamela J. Björkman (17 shared papers)Jeffrey V. Ravetch (6 shared papers)
Journals: Journal of Virology (52 papers)Proceedings of the National Academy of Sciences (15 papers)The Journal of Immunology (10 papers)PLoS Pathogens (9 papers)Cell (8 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Michael S. Seaman

220 papers receiving 14.0k citations

Michael S. Seaman's Hit Papers

align trajectories log scale

Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant 2021 · 190 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Science
2014 Cell
2012 Proceedings of the National Academy of Sciences
2009 Journal of Virology

Peers

Countries citing papers authored by Michael S. Seaman

Since Specialization

Citations

This map shows the geographic impact of Michael S. Seaman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Seaman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Seaman more than expected).

Fields of papers citing papers by Michael S. Seaman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Seaman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Seaman. The network helps show where Michael S. Seaman may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael S. Seaman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael S. Seaman Line = papers co-authored together Michael S. Seaman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 224 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies Journal of Virology ·Michael S. Seaman, Holly Janes, Natalie Hawkins, Lauren E. Grandpre, Colleen Devoy, Ayush Giri, Rory Coffey, Linda Harris, Blake Wood, Marcus Daniels, Tanmoy Bhattacharya, Alan S. Lapedes, Victoria R. Polonis, Francine E. McCutchan, Peter B. Gilbert, Steve Self, Bette Korber, David C. Montefiori, John R. Mascola Hit paper breakdown →	2009	446
2	Complex-type N -glycan recognition by potent broadly neutralizing HIV antibodies Proceedings of the National Academy of Sciences ·Hugo Mouquet, Louise Scharf, Zelda Euler, Yan Liu, Caroline Eden, Johannes F. Scheid, Ariel Halper-Stromberg, Priyanthi N.P. Gnanapragasam, Daniel I. R. Spencer, Michael S. Seaman, Hanneke Schuitemaker, Ten Feizi, Michel C. Nussenzweig, Pamela J. Björkman Hit paper breakdown →	2012	400
3	Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity Cell ·Stylianos Bournazos, Florian Klein, John Pietzsch, Michael S. Seaman, Michel C. Nussenzweig, Jeffrey V. Ravetch Hit paper breakdown →	2014	372
4	Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization Cell ·Florian Klein, Ron Diskin, Johannes F. Scheid, Christian Gaebler, Hugo Mouquet, Ivelin S. Georgiev, Marie Pancera, Tongqing Zhou, Reha‐Baris Incesu, Brooks Zhongzheng Fu, Priyanthi N.P. Gnanapragasam, Thiago Y. Oliveira, Michael S. Seaman, Peter D. Kwong, Pamela J. Björkman, Michel C. Nussenzweig	2013	364
5	Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys Nature ·Jinyan Liu, Kara L. O’Brien, Diana M. Lynch, Nathaniel L. Simmons, Annalena La Porte, Ambryice M. Riggs, Peter Abbink, Rory Coffey, Lauren E. Grandpre, Michael S. Seaman, Gary Landucci, Donald N. Forthal, David C. Montefiori, Angela Carville, Keith G. Mansfield, Menzo Havenga, Maria Grazia Pau, Jaap Goudsmit, Dan H. Barouch	2008	341
6	Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia Nature ·Masashi Shingai, Yoshiaki Nishimura, Florian Klein, Hugo Mouquet, Olivia K. Donau, Ronald J. Plishka, Alicia Buckler‐White, Michael S. Seaman, Michael Piatak, Jeffrey D. Lifson, Dimiter S. Dimitrov, Michel C. Nussenzweig, Malcolm A. Martin	2013	338
7	Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation Nature ·Hugo Mouquet, Johannes F. Scheid, Marie Zöller, Michelle Krogsgaard, René G. Ott, Shetha Shukair, Maxim N. Artyomov, John Pietzsch, Mark Connors, Florencia Pereyra, Bruce D. Walker, David D. Ho, Patrick C. Wilson, Michael S. Seaman, Herman N. Eisen, Arup K. Chakraborty, Thomas J. Hope, Jeffrey V. Ravetch, Hedda Wardemann, Michel C. Nussenzweig	2010	318
8	Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice Cell ·Ariel Halper-Stromberg, Ching-Lan Lu, Florian Klein, Joshua A. Horwitz, Stylianos Bournazos, Lilian Nogueira, Thomas Eisenreich, Cassie Liu, Anna Gazumyan, Uwe Schaefer, Rebecca C. Furze, Michael S. Seaman, Rab K. Prinjha, Alexander Tarakhovsky, Jeffrey V. Ravetch, Michel C. Nussenzweig	2014	299
9	Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design Science ·Ron Diskin, Johannes F. Scheid, Paola Marcovecchio, Anthony P. West, Florian Klein, Han Gao, Priyanthi N.P. Gnanapragasam, Alexander Abadir, Michael S. Seaman, Michel C. Nussenzweig, Pamela J. Björkman	2011	293
10	Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1 Journal of Immunological Methods ·Marcella Sarzotti‐Kelsoe, Robert T. Bailer, Esra Abacı Türk, Lin Chenli, Miroslawa Bilska, Kelli Greene, Hongmei Gao, Christopher A. Todd, Daniel A. Ozaki, Michael S. Seaman, John R. Mascola, David C. Montefiori	2013	290
11	Differential ability of T_h1 and T_h2 T cells to express Fas ligand and to undergo activation-induced cell death International Immunology ·Fred Ramsdell, Michael S. Seaman, Robert E. Miller, Kathleen S. Picha, Mary K. Kennedy, David H. Lynch	1994	290
12	Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys Nature Medicine ·Dan H. Barouch, Kara L. O’Brien, Nathaniel L. Simmons, Sharon L King, Peter Abbink, Lori F. Maxfield, Ying-Hua Sun, Annalena La Porte, Ambryice M. Riggs, Diana M. Lynch, Sarah Clark, Katherine Backus, James Perry, Michael S. Seaman, Angela Carville, Keith G. Mansfield, James Szinger, Will Fischer, Mark Muldoon, Bette Korber	2010	280
13	Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C Journal of Virology ·James Μ. Binley, Elizabeth A. Lybarger, Emma T. Crooks, Michael S. Seaman, Elin S. Gray, Katie L. Davis, Julie M. Decker, Diane Wycuff, Linda Harris, Natalie Hawkins, Blake Wood, Cory Nathe, Douglas D. Richman, Georgia D. Tomaras, Frédéric Bibollet‐Ruche, James E. Robinson, Lynn Morris, George M. Shaw, David C. Montefiori, John R. Mascola	2008	278
14	HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1 Science ·Till Schoofs, Florian Klein, Malte Braunschweig, Edward F. Kreider, Anna Feldmann, Lilian Nogueira, Thiago Y. Oliveira, Julio C. C. Lorenzi, Erica H. Parrish, Gerald H. Learn, Anthony P. West, Pamela J. Björkman, Sarah J. Schlesinger, Michael S. Seaman, Julie Czartoski, M. Juliana McElrath, Nico Pfeifer, Beatrice H. Hahn, Marina Caskey, Michel C. Nussenzweig	2016	227
15	Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection AIDS ·Peter Hraber, Michael S. Seaman, Robert T. Bailer, John R. Mascola, David C. Montefiori, Bette Korber	2013	225
16	Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex Proceedings of the National Academy of Sciences ·Devin Sok, Marit J. van Gils, Matthias Pauthner, Jean‐Philippe Julien, Karen L. Saye-Francisco, Jessica Hsueh, Bryan Briney, Jeong Hyun Lee, Khoa Le, Peter S. Lee, Yuanzi Hua, Michael S. Seaman, John P. Moore, Andrew B. Ward, Ian A. Wilson, Rogier W. Sanders, Dennis R. Burton	2014	221
17	Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape Nature Medicine ·Penny L. Moore, Elin S. Gray, Constantinos Kurt Wibmer, Jinal N. Bhiman, Molati Nonyane, Daniel J. Sheward, Tandile Hermanus, Shringkhala Bajimaya, Nancy Tumba, Melissa-Rose Abrahams, Bronwen E. Lambson, Nthabeleng Ranchobe, Li‐Hua Ping, Nobubelo Ngandu, Quarraisha Abdool Karim, Salim S. Abdool Karim, Ronald Swanstrom, Michael S. Seaman, Carolyn Williamson, Lynn Morris	2012	211
18	Early antibody therapy can induce long-lasting immunity to SHIV Nature ·Yoshiaki Nishimura, Rajeev Gautam, Tae‐Wook Chun, Reza Sadjadpour, Kathryn E. Foulds, Masashi Shingai, Florian Klein, Anna Gazumyan, Jovana Golijanin, Mitzi M. Donaldson, Olivia K. Donau, Ronald J. Plishka, Alicia Buckler‐White, Michael S. Seaman, Jeffrey D. Lifson, Richard A. Koup, Anthony S. Fauci, Michel C. Nussenzweig, Malcolm A. Martin	2017	199
19	Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies Journal of Virology ·Allan C. deCamp, Peter Hraber, Robert T. Bailer, Michael S. Seaman, Christina Ochsenbauer, John C. Kappes, Raphaël Gottardo, Paul T. Edlefsen, Steve Self, Haili Tang, Kelli Greene, Hongmei Gao, Xiaoju Daniell, Marcella Sarzotti‐Kelsoe, Miroslaw K. Górny, Susan Zolla‐Pazner, Celia C. LaBranche, John R. Mascola, Bette Korber, David C. Montefiori	2013	192
20	Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant Science ·Jun Zhang, Tianshu Xiao, Yongfei Cai, Christy L. Lavine, Hanqin Peng, Haisun Zhu, Krishna Anand, Pei Tong, Avneesh Gautam, Megan L. Mayer, Richard M. Walsh, Sophia Rits‐Volloch, Duane R. Wesemann, Wei Yang, Michael S. Seaman, Jianming Lü, Bing Chen Hit paper breakdown →	2021	190

About Michael S. Seaman

Michael S. Seaman is a scholar working on Virology, Immunology, Infectious Diseases, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 224 papers that have together received 14.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (182 papers), Immune Cell Function and Interaction (92 papers), Monoclonal and Polyclonal Antibodies Research (68 papers), HIV/AIDS drug development and treatment (46 papers), T-cell and B-cell Immunology (41 papers), HIV/AIDS Research and Interventions (25 papers), Herpesvirus Infections and Treatments (22 papers) and Immunotherapy and Immune Responses (19 papers). The work is most often cited by research in Virology (9.7k citations), Immunology (7.2k citations), Infectious Diseases (4.5k citations), Radiology, Nuclear Medicine and Imaging (3.5k citations) and Epidemiology (2.5k citations). Michael S. Seaman has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Michel C. Nussenzweig, Florian Klein, David C. Montefiori, John R. Mascola, Johannes F. Scheid, Hugo Mouquet, Pamela J. Björkman, Jeffrey V. Ravetch, Dan H. Barouch and John Pietzsch. Their work appears in journals such as Journal of Virology, Proceedings of the National Academy of Sciences, The Journal of Immunology, PLoS Pathogens and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Michael S. Seaman

Impact in

Papers in i

In The Last Decade

Michael S. Seaman

Michael S. Seaman's Hit Papers

Peers

Countries citing papers authored by Michael S. Seaman

Fields of papers citing papers by Michael S. Seaman

All Works

About Michael S. Seaman

Explore authors with similar magnitude of impact

Papers in